Our results suggest that DPYSL5 may play an important role in t-NEPC development and that DPYSL5 expression is required for prostate cancer cell survival under androgen deprivation, making it an interesting and potential target for drug development. This evidence concerns the gene DPYSL5 and prostate carcinoma.